Systemic Treatment Reduces Von-Hippel-Lindau-Associated Retinal Capillary Hemangioblastoma.
Fairbanks, AM, Hoyek S, and Patel NA. 2022. “Systemic Treatment Reduces Von-Hippel-Lindau-Associated Retinal Capillary Hemangioblastoma.”. Ophthalmology.
Search
Search results
545 results found
Retrospective evaluation of ophthalmological and neurological outcomes for infants born before 24 weeks gestational age in a Swedish cohort
Hellström, Jacobson, Al-Hawasi, Hellström-Westas, Rakow, Johnson, Sävman, et al. 2022. “Retrospective Evaluation of Ophthalmological and Neurological Outcomes for Infants Born before 24 Weeks Gestational Age in a Swedish Cohort”. BMJ Open.
Evaluation of the Visual System by the Primary Care Provider Following Concussion
Master, CL, Bacal, MF Grady, Hertle, AS Shah, Strominger, Whitecross, et al. 2022. “Evaluation of the Visual System by the Primary Care Provider Following Concussion”. Pediatrics.
Bevacizumab in High-Risk Corneal Transplantation: A Pilot Multicenter Prospective Randomized Control Trial
Dohlman, TH, McSoley, Amparo, Carreno-Galeano, Wang, Dastjerdi, RB Singh, et al. 2022. “Bevacizumab in High-Risk Corneal Transplantation: A Pilot Multicenter Prospective Randomized Control Trial”. Ophthalmology.
The Effect of Sample Medication Use on Subsequent Anti-VEGF Agent Selection for Neovascular Age-Related Macular Degeneration
Wai, KM, Begaj, Patil, EM Chen, JB Miller, Kylstra, Aronow, et al. 2022. “The Effect of Sample Medication Use on Subsequent Anti-VEGF Agent Selection for Neovascular Age-Related Macular Degeneration”. Semin Ophthalmol.
Gliovascular alterations in sporadic and familial Alzheimer's disease: APOE3 Christchurch homozygote glioprotection
Henao-Restrepo, Julián, Carolina López-Murillo, Pablo Valderrama-Carmona, Natalia Orozco-Santa, Johana Gomez, Johanna Gutiérrez-Vargas, Renato Moraga, et al. 2022. “Gliovascular Alterations in Sporadic and Familial Alzheimer’s Disease: APOE3 Christchurch Homozygote Glioprotection”. Brain Pathol, e13119.
Retinal degeneration induced in a mouse model of ischemia-reperfusion injury and its management by pemafibrate treatment
Lee, Deokho, Ayaka Nakai, Yukihiro Miwa, Yohei Tomita, Hiromitsu Kunimi, Junhan Chen, Shin-Ichi Ikeda, Kazuo Tsubota, Kazuno Negishi, and Toshihide Kurihara. 2022. “Retinal Degeneration Induced in a Mouse Model of Ischemia-Reperfusion Injury and Its Management by Pemafibrate Treatment”. FASEB J 36 (9): e22497.
Advances in biomaterials for the treatment of retinoblastoma
Farhat, Wissam, Vincent Yeung, Amy Ross, Francesca Kahale, Nikolay Boychev, Liangju Kuang, Lin Chen, and Joseph Ciolino. 2022. “Advances in Biomaterials for the Treatment of Retinoblastoma”. Biomater Sci 10 (19): 5391-5429.
The Treatment of Myelin Oligodendrocyte Glycoprotein Antibody Disease: A State-of-the-Art Review
Chwalisz, Bart, and Michael Levy. 2022. “The Treatment of Myelin Oligodendrocyte Glycoprotein Antibody Disease: A State-of-the-Art Review”. J Neuroophthalmol 42 (3): 292-96.
Multicenter prospective validation study for international chronic ocular graft-versus-host disease consensus diagnostic criteria
Ogawa, Yoko, Reza Dana, Stella Kim, Sandeep Jain, Mark Rosenblatt, Victor Perez, Janine Clayton, et al. 2022. “Multicenter Prospective Validation Study for International Chronic Ocular Graft-versus-Host Disease Consensus Diagnostic Criteria”. Ocul Surf 26: 200-208.